GSK3B and proximal spinal muscular atrophy: Moreover, potent and reasonably selective GSK-3β inhibition proved to prolong the median survival of a transgenic Δ7 SMA KO mouse model of SMA and showed neuroprotective effects in a cell-based SMA-related model of oxidative stress-induced neurodegeneration [21].